Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University — Chicago, Illinois

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University has participated in 1 clinical trials.

Therapeutic areas: Primary Progressive Aphasia, Caregiver Burnout.

Sponsors: Northwestern University.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University?

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University conducted?

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University has 1 clinical trials on record. Their work covers Primary Progressive Aphasia, Caregiver Burnout.

Is Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University accredited by Crixeo Health?

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.